1. Home
  2. SRPT vs AU Comparison

SRPT vs AU Comparison

Compare SRPT & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • AU
  • Stock Information
  • Founded
  • SRPT 1980
  • AU 1944
  • Country
  • SRPT United States
  • AU United States
  • Employees
  • SRPT N/A
  • AU N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • AU Precious Metals
  • Sector
  • SRPT Health Care
  • AU Basic Materials
  • Exchange
  • SRPT Nasdaq
  • AU Nasdaq
  • Market Cap
  • SRPT 12.2B
  • AU 10.3B
  • IPO Year
  • SRPT 1997
  • AU 1972
  • Fundamental
  • Price
  • SRPT $120.25
  • AU $23.13
  • Analyst Decision
  • SRPT Buy
  • AU Hold
  • Analyst Count
  • SRPT 21
  • AU 5
  • Target Price
  • SRPT $179.38
  • AU $31.75
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • AU 4.8M
  • Earning Date
  • SRPT 11-06-2024
  • AU 11-07-2024
  • Dividend Yield
  • SRPT N/A
  • AU 0.93%
  • EPS Growth
  • SRPT N/A
  • AU N/A
  • EPS
  • SRPT 1.22
  • AU 1.34
  • Revenue
  • SRPT $1,640,348,000.00
  • AU $5,299,000,000.00
  • Revenue This Year
  • SRPT $50.40
  • AU $31.43
  • Revenue Next Year
  • SRPT $71.44
  • AU $21.09
  • P/E Ratio
  • SRPT $99.10
  • AU $17.98
  • Revenue Growth
  • SRPT 48.45
  • AU 17.78
  • 52 Week Low
  • SRPT $89.92
  • AU $15.80
  • 52 Week High
  • SRPT $173.25
  • AU $32.57
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 44.95
  • AU 36.25
  • Support Level
  • SRPT $122.12
  • AU $24.85
  • Resistance Level
  • SRPT $128.73
  • AU $27.22
  • Average True Range (ATR)
  • SRPT 4.13
  • AU 0.65
  • MACD
  • SRPT -0.38
  • AU -0.12
  • Stochastic Oscillator
  • SRPT 2.16
  • AU 1.33

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

Share on Social Networks: